Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

BACKGROUND: Intravenous recombinant tissue plasminogen activator (rtPA) is approved in Europe for use in patients with acute ischaemic stroke who meet strictly defined criteria. IST-3 sought to improve the external validity and precision of the estimates of the overall treatment effects (efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandercock, Peter, Lindley, Richard, Wardlaw, Joanna, Dennis, Martin, Innes, Karen, Cohen, Geoff, Whiteley, Will, Perry, David, Soosay, Vera, Buchanan, David, Venables, Graham, Czlonkowska, Anna, Kobayashi, Adam, Berge, Eivind, Slot, Karsten Bruins, Murray, Veronica, Peeters, Andre, Hankey, Graeme J, Matz, Karl, Brainin, Michael, Ricci, Stefano, Cantisani, Teresa A, Gubitz, Gordon, Phillips, Stephen J, Antonio, Arauz, Correia, Manuel, Lyrer, Phillippe, Kane, Ingrid, Lundstrom, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286387/
https://www.ncbi.nlm.nih.gov/pubmed/22129158
http://dx.doi.org/10.1186/1745-6215-12-252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286387/
https://www.ncbi.nlm.nih.gov/pubmed/22129158
http://dx.doi.org/10.1186/1745-6215-12-252

Ejemplares similares